Sponsor Pipeline

Cognition Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT05531656
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease		 date change Primary completion pushed: 2027-04 -> 2027-05-31
2026-08-11 NCT05531656
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease		 date change Completion pushed: 2027-04 -> 2027-05-31
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05531656 A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Early Alzheimer's Disease Active, Not Recruiting
Disease Areas
Alzheimer's Disease (1)
Get alerts when Cognition Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free